Danes review UK/French proposal on CNS (central nervous system) devices:
This article was originally published in Clinica
Executive Summary
The Danish medical device industry association, Medicoindustrien, is seeking the views of its members on one of the controversial proposals put forward by the French and UK authorities which are intended to tighten the requirements of the Medical Devices Directive (MDD). It is asking for comments on the UK and French proposal that invasive devices intended for use in the central nervous system for less than 60 minutes be placed in class III, the highest risk class, in future. At present, Rule 6 of the MDD generally places invasive devices for transient use in class IIa.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.